Discrete Choice Experiment to Evaluate Factors That Influence Preferences for Antibiotic Prophylaxis in Pediatric Oncology

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Regier, Dean A ^a   Diorio, Caroline ^b   Ethier, Marie Chantal ^b,c   Alli, Amanda ^b   Alexander, Sarah ^b   Boydell, Katherine M ^b   Gassas, Adam ^b   Taylor, Jonathan ^b   Kellow, Charis ^b   Mills, Denise ^b   Sung, Lillian ^b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; COTRIMOXAZOLE; FLUCONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ATTITUDE TO HEALTH; BACTERIAL INFECTION; CANCER RECURRENCE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DECISION MAKING; DISCRETE CHOICE EXPERIMENT; DRUG ADMINISTRATION ROUTE; DRUG CHOICE; DRUG COST; EXPERIMENTATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; NONHUMAN; PNEUMOCYSTIS PNEUMONIA; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; TASK PERFORMANCE; TREATMENT INDICATION; TREATMENT RESPONSE; WILLINGNESS TO PAY;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; CHILD; CHOICE BEHAVIOR; FEMALE; HEALTH PERSONNEL; HUMANS; LOGISTIC MODELS; MALE; MEDICAL ONCOLOGY; PATIENT PREFERENCE;

EID: 84867649473     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047470     Document Type: Article

References (13)

1. Sung L, Lange BJ, Gerbing RB, Alonzo TA, Feusner J, (2007) Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood 110: 3532-3539.
2. Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH, (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106: 2258-2266.
3. Gafter-Gvili A, Fraser A, Paul M, Leibovici L, (2005) Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 142: 979-995.
4. Robenshtok E, Gafter-Gvili A, Goldberg E, Weinberger M, Yeshurun M, et al. (2007) Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol 25(34): 5471-5489.
5. Lehrnbecher L, Ethier MC, Zaoutis T, Creutzig U, Gamis A, et al. (2009) International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia. Br J Haematol 147: 125-128.
6. Ryan M, Farrar S, (2000) Using conjoint analysis to elicit preferences for health care. Brit Med J 320: 1530-1533.
7. Lancaster K, (1966) A new approach to consumer theory. J Polit Econ 74: 132-157.
8. Street D, Burgess L (2007) The Construction of Optimal Stated Choice Experiments: Theory and Methods. Hoboken, New Jersey: Wiley.
9. Louviere J, Hensher D, Swait J (2002) Stated choice methods: Analysis and applications. Cambridge: Cambridge University Press.
10. Louviere JJ, Hensher DA, Swait J (2000) Stated choice methods: Analysis and applications. Cambridge: Cambridge University Press.
11. Small KA, Rosen HS, (1981) Applied welfare economics with discrete choice models. Econometrica 49: 105-130.
12. Telser H, Zweifel P, (2002) Measuring willingness-to-pay for risk reduction: an application of conjoint analysis. Health Econ 11: 129-139.
13. Regier DA, Friedman JM, Marra CA, (2010) Value for money? Array genomic hybridization for genetic causes of intellectual disability. American Journal of Human Genetics 86(5): 765-772.